IGF::OT::IGF - BASE PERIOD AWARD TO INBIOS INTERNATIONAL, INC. FOR POINT-OF-CARE IMMUNOASSAY FOR DIAGNOSIS OF INHALATIONAL ANTHRAX
$8,094,146
| Recipient | INBIOS INTERNATIONAL INC UEI CNJNQ1GMSN55 |
|---|---|
| Award ID | HHSO100201700029C |
| Award amount | $8,094,146 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
| PSC | AN11 |
| Start date | Sep 26, 2017 |
| End date | Jun 30, 2023 |
| Place of performance | SEATTLE, WA |
| Record updated | Jul 14, 2022 |
View the official award record
More awards won by INBIOS INTERNATIONAL INC
DIAGNOSTIC TESTING IDIQ
Department of Health and Human Services · $148,000,000 · Sep 30, 2025
COVID-19 OTC TEST KIT
Department of Defense · $52,000,000 · Feb 17, 2022
COVID-19-FDA EUA ANTIGEN DETECTION- FDA FAST TRACK SEROLOGY ASSAY OPTIMIZATION
Department of Defense · $25,655,995 · Jun 15, 2020
OVER THE COUNTER (OTC) COVID-19 TESTS
Department of Health and Human Services · $20,736,000 · Sep 20, 2023
IGF::OT::IGF INBIOS - DEVELOPMENT OF POINT-OF-CARE ANDLABORATORY-BASED IMMUNOASSAYS FOR PRESUMPTIVE DIAGNOSIS OF ZIKA VIRUS INFECTION
Department of Health and Human Services · $7,735,011 · Jul 27, 2016
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids